The 2019 Investing in Cures Summit was held
on March 1–2 in Raleigh, North Carolina, and
brought together a cross section of industry
partners, investors, researchers and other select
members of the community. In total, there
were 165 attendees from across the country
who witnessed presentations on the latest
advancements in clinical trials and industry
partnerships. The summit featured presenters
from around the world, including translational
research experts, clinical trial investigators,
and the companies that are poised to take
emerging therapies across the finish line. In
addition, leadership from the Foundation’s newly
launched Retinal Degeneration Fund (RD Fund)
presented on investment plans and goals for the
future to get more treatments through human
studies and out into the marketplace. Please
contact us if you are interested in learning more
about this event.
The Investing in Cures Summit was hosted by the
Foundation Fighting Blindness and the RD Fund.
Thanks to our Seed Partners, Eloxx Pharmaceuticals
Hosted by tri-state area volunteers, the 3rd
Annual New York Taste for Sight welcomed
beer, wine and spirits vendors for a tasting
event at City Winery in New York City. The
event, complete with a silent auction, “cork
pull” and live entertainment by Eddy Echo, was
a resounding success and raised more than
$154,000 for sight-saving retinal degenerative
2019 Investing in
‘New York Taste for Sight’ in
its Third Year Raising Funds
TOP: Bradford Manning (on left) and Bryan
Manning (on right) from Two Blind Brothers.
Bradford and Bryan Manning were our keynote
presenters Friday evening at the Reception
Dinner at the Investing in Cures Summit.
BOTTOM: Treasurer Haynes Lea participating
in the Q&A discussion of the Public Company
Forum on Saturday at the ICS program portion.
ABOVE: Eddy Echo, son of National Trustee
Ed Babin and affected with Stargardt disease,
performing one of his original songs after
sharing his personal story.